VanEck Vectors Generic Drugs ETF (GNRX) Declines 1% for Jul 17

July 17, 2017 - By Peter Erickson

Jul 17 is a negative day so far for VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) as the ETF is active during the day after losing 1% to hit $22.87 per share. The exchange traded fund has 3.46 million net assets and 1.33% volatility this month.

Over the course of the day 24,843 shares traded hands, as compared to an average volume of 1,490 over the last 30 days for VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX).

The ETF is -13.90% of its 52-Week High and 2.39% of its low, and is currently having ATR of 0.4. This year’s performance is -11.26% while this quarter’s performance is -13.33%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More notable recent VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) news were published by: Marketwatch.com which released: “VanEck Vectors Generic Drugs ETF” on January 13, 2016, also Marketwatch.com with their article: “Generic-drug maker ETF could outperform biotech peers under Clinton” published on November 08, 2016, Etfdailynews.com published: “This Generic Drug ETF Deserves Consideration Amid Biotech Weakness” on October 05, 2016. More interesting news about VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) were released by: Marketwatch.com and their article: “VanEck Vectors Pharmaceutical ETF” published on June 05, 2010 as well as Businesswire.com‘s news article titled: “VanEck Announces Preliminary Year-End Distribution Estimates for VanEck …” with publication date: November 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.